๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Xiangyang
Clinical trial register · China

Clinical Trials in Xiangyang, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Huazhong University of Science and Technology3 Ab&B Bio-tech Co., Ltd.JS2 Renmin Hospital of Wuhan University2 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 Chen Xiaoping1
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Xiangyang

33 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Bao Yuan Tang Extract and Galactooligosaccharides for Sleep Regulation
NCT07774897Sleep Disturbance, Fatigue Syndrome, Chronic, Endocrine Disorder, Glucose Metabolism Disorder
Hepatopancreatobiliary Surgery Institute of Gansu Province
Not applicable
400
Lanzhou, Shijiazhuang, Xiangyang, รœrรผmqi, Kunming
2026-09-30
Recruiting
Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC
NCT07741448UTUC
DrugsTrastuzumab Rezetecan·Gemcitabine
Zhiquan Hu
Phase 2
54
Huanggang, Jingzhou, Shiyan, Wuhan, Xiangyang, Yichang
2026-08-15
Not yet open
RCT Study on the Effect of ETN on Live Birth Rate in DOR Patients Undergoing IVF-ET
NCT07769684Diminished Ovarian Reserve (DOR), Infertility (IVF Patients)
Huazhong University of Science and Technology
Not applicable
406
Shiyan, Wuhan, Xiangyang
2026-08-01
Not yet open
Effects of Inulin on Cardiometabolic Risk Factors in Individuals Using Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA ) Medications for Weight Loss
NCT07611552Obesity & Overweight
Huazhong University of Science and Technology
Not applicable
600
Enshi, Shiyan, Wuhan, Xiangyang
2026-06
Recruiting
Low-Intensity Focused Ultrasound Targeting the Stellate Ganglion for Regulating Autonomic Nerve Function and Sleep Quality in Perioperative Patients With Cardiovascular Diseases
NCT07595068Atrial Fibrillation (AF), Cardiovascular Diseases
Renmin Hospital of Wuhan University
Not applicable
200
Huangshi, Jingzhou, Wuhan, Xiangyang, Yichang
2026-05-20
Recruiting
Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patients With ST-segment Elevation Myocardial Infarction
NCT07587294Acute ST-segment Elevation Myocardial Infarction (Patients Undergoing Emergency PCI)
Renmin Hospital of Wuhan University
Not applicable
100
Huangshi, Jingzhou, Shiyan, Wuhan, Xiangyang
2026-05-15
Active, closed
A Clinical Trial of Rabies Vaccine๏ผˆHuman Diploid Cell๏ผ‰for Human Use,Freeze-dried in a Population Aged 10 to 60 Years
NCT07275645Rabies
Ab&B Bio-tech Co., Ltd.JS
Phase 3
3,000
Huanggang, Shiyan, Xiangyang
2026-02-26
Recruiting
Exploratory Study of Orelabrutinib in the Treatment of Early-stage Untreated MZL
NCT07441993Marginal Zone Lymphoma
DrugOrelabrutinib
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
30
Guangzhou, Zhengzhou, Wuhan, Xiangyang, Changsha, Nanjing, Nantong, Nanchang
2026-01-05
Not yet open
ICSI Versus Conventional IVF in Couples With Unexplained Infertility
NCT07294027Unexplained Infertility
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
848
Beijing, Huangshi, Wuhan, Xiangyang, Hangzhou, Jiaxing, Ningbo
2026-01-01
Not yet open
A Multicenter Study on the Normal Reference Range and Clinical Significance of the Right Atrioventricular Coupling Index Assessed by Artificial Intelligence-Based Three-Dimensional Echocardiography
NCT07292896Healthy Adults, Pulmonary Hypertension, Tricuspid Regurgitation, Heart Failure
First Hospital of China Medical University
Observational
2,640
Chongqing, Shenzhen, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Xiangyang, Changchun
2025-12
Not yet open
Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia Syndrome
NCT07240376Non-Allergic Rhinitis With Eosinophilia Syndrome
DrugStapokibart
Huazhong University of Science and Technology
Not applicable
90
Guangzhou, Wuhan, Xiangyang, Nanchang, Chengdu, Beijing, Shanghai
2025-11-25
Recruiting
Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years
NCT07300644Pneumococcal Infectious Disease
Sinovac Life Sciences Co., Ltd.
Phase 2
420
Huanggang, Xiangyang, Xianning
2025-11-25
Active, closed
Clinical Trial of Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older
NCT07421050Influenza, Influenza Vaccine
DrugMF59
Ab&B Bio-tech Co., Ltd.JS
Phase 1
80
Xiangyang
2025-11-13
Recruiting
A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
NCT07111546Advanced Solid Tumour
DrugsLBL-024·Gemcitabine Hydrochloride·Cisplatin·Bevacizumab
Nanjing Leads Biolabs Co.,Ltd
Phase 2
140
Hefei, Fuzhou, Guangzhou, Nanning, Harbin, Zhengzhou, Xiangyang, Changsha
2025-10-20
Recruiting
Burst Stimulation for Paroxysmal Atrial Fibrillation
NCT07281898Paroxysmal Atrial Fibrillation
Zhibing Lu
Not applicable
240
Wuhan, Xiangyang, Yichang
2025-10-13
Recruiting
A Study of SKB518 in Patients With Lung Cancer
NCT07019675Lung Carcinoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
192
Shenzhen, Nanning, Zhengzhou, Wuhan, Xiangyang, Changsha, Nanchang, Jinan
2025-08-29
Recruiting
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
NCT06892548Advanced Lung Cancer
DrugsBNT324·Pumitamig
BioNTech SE
Phase 1/2
594
Hefei, Beijing, Fuzhou, Nanning, Weihui, Zhengzhou, Jingzhou, Xiangyang
2025-05-02
Recruiting
The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus
NCT07128186Cognitive Dysfunction
Tongji Hospital
Observational
5,000
Enshi, Huanggang, Huangshi, Jingzhou, Shiyan, Suizhou, Wuhan, Xiangyang
2025-04-22
Recruiting
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
NCT06790693Breast Cancer
DrugsCDK4/6i·Inavolisib·Letrozole
Hoffmann-La Roche
Phase 3
450
Xiangyang, Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Harbin, Jiangmen
2025-04-09
Recruiting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
NCT06841354Triple Negative Breast Neoplasms
DrugsSacituzumab tirumotecan·Nab-paclitaxel·Gemcitabine·Carboplatin
Merck Sharp & Dohme LLC
Phase 3
1,000
Bengbu, Chongqing, Xiamen, Guangzhou, Nanning, Zhengzhou, Wuhan, Xiangyang
2025-03-16
Recruiting
IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial
NCT06654011Cervical Adenocarcinoma, Gastric-type Endocervical Adenocarcinoma
DrugsIN10018·Cadonilimab·Nab-paclitaxel
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
25
Wuhan, Xiangyang
2025-02-17
Recruiting
Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients
NCT06696794Non-Muscle-Invasive Bladder Cancer (NMIBC)
Shaogang Wang
Phase 3
180
Wuhan, Xiangyang
2025-02-17
Recruiting
A Study in Chinese Patients With Acquired Blepharoptosis
NCT06683651Blepharoptosis
Santen Pharmaceutical Co., Ltd.
Phase 3
180
Hefei, Beijing, Shantou, Guiyang, Zhengzhou, Haโ€™erbin, Wuhan, Xiangyang
2024-10-22
Recruiting
Thumbtack Needle in the Treatment of NVP
NCT06566274Nausea and Vomiting in Pregnancy (NVP)
Dongmei Huang
Not applicable
320
Jingzhou, Nanzhang Chengguanzhen, Qianjiang, Shiyan, Suizhou, Wuhan, Xiangyang, Xiaogan
2024-10-01
Recruiting
Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection
NCT06734260Helicobacter Pylori Eradication Rate
DrugAmoxicillin
Eighth Affiliated Hospital, Sun Yat-sen University
Phase 3
477
Guangzhou, Puning, Shenzhen, Xiangyang
2024-09-10
Not yet open
A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients
NCT06469879Small Cell Lung Cancer Limited Stage
DrugsEtoposide·Dexamethasone
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
358
Hefei, Lanzhou, Nanjing, Tangshan, Harbin, Anyang, Xiangyang, Changsha
2024-09
Recruiting
Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model
NCT06420440HCC
DrugsLenvatinib·Tislelizumab
Chen Xiaoping
Phase 2
160
Xiangyang, Jinan
2024-06-01
Recruiting
A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
NCT06300320Chronic Graft Versus Host Disease
DrugRovadicitinib
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
65
Hefei, Lanzhou, Guangzhou, Nanning, Shijiazhuang, Xiangyang, Taian, Shanghai
2024-05-07
Recruiting
Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion
NCT06155032Stroke, Ischemic, Cerebrovascular; Disorder, Occlusive
First Affiliated Hospital of Wannan Medical College
Not applicable
272
Fuyang, Hefei, Huainan, Huangshan City, Suzhou, Wuhu, Xiangyang
2024-01-04
Recruiting
Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
NCT05872347Breast Cancer Brain Metastases
DrugSPH4336
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 2
52
Hefei, Guangzhou, Liuzhou, Anyang, Luoyang, Shijiazhuang, Harbin, Xiangyang
2023-09-19
Active, closed
A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer
NCT05227664Metastatic Triple-negative Breast Cancer, Locally Advanced Triple-negative Breast Cancer
DrugsAK117·Nab-paclitaxel·Paclitaxel·Bevacizumab
Akeso
Phase 2
120
Changsha, Xiangyang
2022-03-23
Active, closed
Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China
NCT05144243Acute Myeloid Leukemia (AML)
DrugVenetoclax
AbbVie
Phase 4
44
Beijing, Guangzhou, Shenzhen, Zhengzhou, Wuhan, Xiangyang, Suzhou, Nanchang
2022-01-06
Active, closed
SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies
NCT04684108Relapsed or Refractory Multiple Myeloma, Hematological Malignancy
DrugSG301
Hangzhou Sumgen Biotech Co., Ltd.
Phase 1
61
Bengbu, Beijing, Shenzhen, Shijiazhuang, Zhengzhou, Wuhan, Xiangyang, Wuxi
2021-11-04
Rows per page Showing 1–33 of 33
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/city/xiangyang

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 33 of those studies with a site in Xiangyang.

How many clinical trials are recruiting in Xiangyang?

21 of the 33 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 7 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Xiangyang), 33 studies
PhaseStudiesRecruitingShare
Not applicable10530.3%
Phase 210930.3%
Phase 37521.2%
Observational216.1%
Phase 1206.1%
Phase 1/2113%
Phase 4103%

Most active sponsors

Lead sponsors with the most studies (Xiangyang)
Lead sponsorStudiesRecruiting
Huazhong University of Science and Technology30
Ab&B Bio-tech Co., Ltd.JS20
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.21
Renmin Hospital of Wuhan University22
AbbVie10
Akeso10
BioNTech SE11
Chen Xiaoping11
Dongmei Huang11
Eighth Affiliated Hospital, Sun Yat-sen University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.